Activity of CoII–Quinalizarin: A Novel Analogue of Anthracycline-Based Anticancer Agents Targets Human DNA Topoisomerase, Whereas Quinalizarin Itself Acts via Formation of Semiquinone on Acute Lymphoblastic Leukemia MOLT‑4 and HCT 116 Cells

Activity of CoII–Quinalizarin: A Novel Analogue of Anthracycline-Based Anticancer Agents Targets Human DNA Topoisomerase, Whereas Quinalizarin Itself Acts via Formation of Semiquinone on Acute Lymphoblastic Leukemia MOLT‑4 and HCT 116 Cells

Bibliographic Details
Main Authors: Sayantani Mukherjee Chatterjee, Chetan Kumar Jain, Soumen Singha, Piyal Das, Susanta Roychoudhury, Hemanta Kumar Majumder, Saurabh Das
Format: Article
Language:English
Published: American Chemical Society 2018-08-01
Series:ACS Omega
Online Access:http://dx.doi.org/10.1021/acsomega.8b00706

Internet

http://dx.doi.org/10.1021/acsomega.8b00706

Similar Items